168 related articles for article (PubMed ID: 26322020)
1. RXFP1 is Targeted by Complement C1q Tumor Necrosis Factor-Related Factor 8 in Brain Cancer.
Thanasupawat T; Glogowska A; Burg M; Wong GW; Hoang-Vu C; Hombach-Klonisch S; Klonisch T
Front Endocrinol (Lausanne); 2015; 6():127. PubMed ID: 26322020
[TBL] [Abstract][Full Text] [Related]
2. C1q/TNF-Related Proteins 1, 6 and 8 Are Involved in Corneal Epithelial Wound Closure by Targeting Relaxin Receptor RXFP1 In Vitro.
Nicolaus HF; Klonisch T; Paulsen F; Garreis F
Int J Mol Sci; 2023 Apr; 24(7):. PubMed ID: 37047812
[TBL] [Abstract][Full Text] [Related]
3. C1q-tumour necrosis factor-related protein 8 (CTRP8) is a novel interaction partner of relaxin receptor RXFP1 in human brain cancer cells.
Glogowska A; Kunanuvat U; Stetefeld J; Patel TR; Thanasupawat T; Krcek J; Weber E; Wong GW; Del Bigio MR; Hoang-Vu C; Hombach-Klonisch S; Klonisch T
J Pathol; 2013 Dec; 231(4):466-79. PubMed ID: 24014093
[TBL] [Abstract][Full Text] [Related]
4. Novel CTRP8-RXFP1-JAK3-STAT3 axis promotes Cdc42-dependent actin remodeling for enhanced filopodia formation and motility in human glioblastoma cells.
Glogowska A; Thanasupawat T; Beiko J; Pitz M; Hombach-Klonisch S; Klonisch T
Mol Oncol; 2022 Jan; 16(2):368-387. PubMed ID: 33960104
[TBL] [Abstract][Full Text] [Related]
5. Human C1q Tumor Necrosis Factor 8 (CTRP8) defines a novel tryptase+ mast cell subpopulation in the prostate cancer microenvironment.
Krishnan SN; Thanasupawat T; Arreza L; Wong GW; Sfanos K; Trock B; Arock M; Shah GG; Glogowska A; Ghavami S; Hombach-Klonisch S; Klonisch T
Biochim Biophys Acta Mol Basis Dis; 2023 Jun; 1869(5):166681. PubMed ID: 36921737
[TBL] [Abstract][Full Text] [Related]
6. Structural commonality of C1q TNF-related proteins and their potential to activate relaxin/insulin-like family peptide receptor 1 signalling pathways in cancer cells.
Klonisch T; Glogowska A; Thanasupawat T; Burg M; Krcek J; Pitz M; Jaggupilli A; Chelikani P; Wong GW; Hombach-Klonisch S
Br J Pharmacol; 2017 May; 174(10):1025-1033. PubMed ID: 27443788
[TBL] [Abstract][Full Text] [Related]
7. Emerging roles for the relaxin/RXFP1 system in cancer therapy.
Thanasupawat T; Glogowska A; Nivedita-Krishnan S; Wilson B; Klonisch T; Hombach-Klonisch S
Mol Cell Endocrinol; 2019 May; 487():85-93. PubMed ID: 30763603
[TBL] [Abstract][Full Text] [Related]
8. CTRP8 and CTRP9B are novel proteins that hetero-oligomerize with C1q/TNF family members.
Peterson JM; Wei Z; Wong GW
Biochem Biophys Res Commun; 2009 Oct; 388(2):360-5. PubMed ID: 19666007
[TBL] [Abstract][Full Text] [Related]
9. Relaxin family peptide receptors Rxfp1 and Rxfp2: mapping of the mRNA and protein distribution in the reproductive tract of the male rat.
Filonzi M; Cardoso LC; Pimenta MT; Queiróz DB; Avellar MC; Porto CS; Lazari MF
Reprod Biol Endocrinol; 2007 Jul; 5():29. PubMed ID: 17623071
[TBL] [Abstract][Full Text] [Related]
10. The chemically synthesized human relaxin-2 analog, B-R13/17K H2, is an RXFP1 antagonist.
Hossain MA; Samuel CS; Binder C; Hewitson TD; Tregear GW; Wade JD; Bathgate RA
Amino Acids; 2010 Jul; 39(2):409-16. PubMed ID: 20043231
[TBL] [Abstract][Full Text] [Related]
11. Complement 1q/Tumor Necrosis Factor-Related Proteins (CTRPs): Structure, Receptors and Signaling.
Schanbacher C; Hermanns HM; Lorenz K; Wajant H; Lang I
Biomedicines; 2023 Feb; 11(2):. PubMed ID: 36831095
[TBL] [Abstract][Full Text] [Related]
12. C1q/TNF-related protein-3 represents a novel and endogenous lipopolysaccharide antagonist of the adipose tissue.
Kopp A; Bala M; Buechler C; Falk W; Gross P; Neumeier M; Schölmerich J; Schäffler A
Endocrinology; 2010 Nov; 151(11):5267-78. PubMed ID: 20739398
[TBL] [Abstract][Full Text] [Related]
13. Serum levels of C1q/TNF-related protein-1 (CTRP-1) are closely associated with coronary artery disease.
Wang H; Wang R; Du D; Li F; Li Y
BMC Cardiovasc Disord; 2016 May; 16():92. PubMed ID: 27169633
[TBL] [Abstract][Full Text] [Related]
14. Role of the CTRP family in tumor development and progression.
Kong M; Gao Y; Guo X; Xie Y; Yu Y
Oncol Lett; 2021 Oct; 22(4):723. PubMed ID: 34429763
[TBL] [Abstract][Full Text] [Related]
15. RXFP1-inactive relaxin activates human glucocorticoid receptor: further investigations into the relaxin-GR pathway.
Dschietzig T; Bartsch C; Baumann G; Stangl K
Regul Pept; 2009 Apr; 154(1-3):77-84. PubMed ID: 19101597
[TBL] [Abstract][Full Text] [Related]
16. Comparison of signaling pathways activated by the relaxin family peptide receptors, RXFP1 and RXFP2, using reporter genes.
Halls ML; Bathgate RA; Summers RJ
J Pharmacol Exp Ther; 2007 Jan; 320(1):281-90. PubMed ID: 17065365
[TBL] [Abstract][Full Text] [Related]
17. Probing the functional domains of relaxin-3 and the creation of a selective antagonist for RXFP3/GPCR135 over relaxin receptor RXFP1/LGR7.
Liu C; Kuei C; Sutton S; Shelton J; Zhu J; Nepomuceno D; Hossain MA; Wade JD; Bathgate RA; Bonaventure P; Lovenberg T
Ann N Y Acad Sci; 2009 Apr; 1160():31-7. PubMed ID: 19416155
[TBL] [Abstract][Full Text] [Related]
18. Relaxin family peptide receptor (RXFP1) coupling to G(alpha)i3 involves the C-terminal Arg752 and localization within membrane Raft Microdomains.
Halls ML; van der Westhuizen ET; Wade JD; Evans BA; Bathgate RA; Summers RJ
Mol Pharmacol; 2009 Feb; 75(2):415-28. PubMed ID: 19029286
[TBL] [Abstract][Full Text] [Related]
19. Activation of Relaxin Family Receptor 1 from Different Mammalian Species by Relaxin Peptide and Small-Molecule Agonist ML290.
Huang Z; Myhr C; Bathgate RA; Ho BA; Bueno A; Hu X; Xiao J; Southall N; Barnaeva E; Agoulnik IU; Marugan JJ; Ferrer M; Agoulnik AI
Front Endocrinol (Lausanne); 2015; 6():128. PubMed ID: 26347712
[TBL] [Abstract][Full Text] [Related]
20. Relaxin family peptide receptors RXFP1 and RXFP2 modulate cAMP signaling by distinct mechanisms.
Halls ML; Bathgate RA; Summers RJ
Mol Pharmacol; 2006 Jul; 70(1):214-26. PubMed ID: 16569707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
